Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eli Lilly Hires AstraZeneca's Jan Lundberg To Replace Steve Paul As Head Of R&D

This article was originally published in The Pink Sheet Daily

Executive Summary

The move comes amid a vast R&D reorganization at Lilly which, like AstraZeneca, is laboring to speed compounds into and through development.
Advertisement

Related Content

R&D Swapping: AstraZeneca Lures Mackay From Pfizer To Head Global R&D
R&D Swapping: AstraZeneca Lures Mackay From Pfizer To Head Global R&D
AstraZeneca Reports Higher Profits, But Cuts R&D Jobs
AstraZeneca Reports Higher Profits, But Cuts R&D Jobs
Lilly Plays Up R&D Productivity With Reorganization
Lilly Plays Up R&D Productivity With Reorganization
Eyeing The Future: AstraZeneca Farms Out Compounds To Ocular Specialist Alcon

Topics

Advertisement
UsernamePublicRestriction

Register

PS068745

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel